Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6763659> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q6763659 subject Q8529502.
- Q6763659 abstract "Marimastat was a proposed antineoplastic drug developed by British Biotech. It acted as a broad-spectrum matrix metalloproteinase inhibitor.Marimastat performed poorly in clinical trials, and development was terminated.".
- Q6763659 atcPrefix "none".
- Q6763659 casNumber "154039-60-8".
- Q6763659 drugbank "DB00786".
- Q6763659 fdaUniiCode "D5EQV23TDS".
- Q6763659 iupacName "N-[2,2-dimethyl-1- (methylcarbamoyl)propyl]-2-[hydroxy-(hydroxycarbamoyl)methyl]- 4- methyl-pentanamide".
- Q6763659 pubchem "119031".
- Q6763659 thumbnail Marimastat.png?width=300.
- Q6763659 wikiPageWikiLink Q15303190.
- Q6763659 wikiPageWikiLink Q16241012.
- Q6763659 wikiPageWikiLink Q16966320.
- Q6763659 wikiPageWikiLink Q8529502.
- Q6763659 wikiPageWikiLink Q974135.
- Q6763659 atcPrefix "none".
- Q6763659 casNumber "154039".
- Q6763659 drugbank "DB00786".
- Q6763659 iupacName "N-[2,2-dimethyl-1- propyl]-2- [hydroxy-methyl]- 4- methyl-pentanamide".
- Q6763659 pubchem "119031".
- Q6763659 unii "D5EQV23TDS".
- Q6763659 type ChemicalSubstance.
- Q6763659 type Drug.
- Q6763659 type ChemicalObject.
- Q6763659 type Thing.
- Q6763659 type Q8386.
- Q6763659 comment "Marimastat was a proposed antineoplastic drug developed by British Biotech. It acted as a broad-spectrum matrix metalloproteinase inhibitor.Marimastat performed poorly in clinical trials, and development was terminated.".
- Q6763659 label "Marimastat".
- Q6763659 depiction Marimastat.png.